Kara Cannon - 24 Mar 2022 Form 4 Insider Report for ENZO BIOCHEM INC (ENZB)

Role: Chief Operating Officer
Signature: /s/ Kara Cannon
Issuer symbol: ENZB
Transactions as of: 24 Mar 2022
Net transactions value: $0
Form type: 4
Filing time: 28 Mar 2022, 18:03:22 UTC
Next filing: 19 Jul 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	ENZ	Common Stock, $0.01 Par Value						22,614	24 Mar 2022	401k

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ENZ	Stock Option (to acquire Common Stock)	Award	$0	+87,500		$0.000000	87,500	24 Mar 2022	Common Stock	87,500	$2.98	Direct	F1
holding	ENZ	Stock Option (to acquire Common Stock)						87,500	24 Mar 2022	Common Stock	87,500	$3.36	Direct	F1
holding	ENZ	Stock Option (to acquire Common Stock)						55,400	24 Mar 2022	Common Stock	55,400	$2.63	Direct	F1
holding	ENZ	Stock Option (to acquire Common Stock)						55,400	24 Mar 2022	Common Stock	55,400	$2.20	Direct	F1
holding	ENZ	Stock Option (to acquire Common Stock)						52,000	24 Mar 2022	Common Stock	52,000	$2.80	Direct	F1
holding	ENZ	Stock Option (to acquire Common Stock)						35,000	24 Mar 2022	Common Stock	35,000	$4.42	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The stock options have a five-year term and will vest in three equal installments, one on the first anniversary of the grant date, the second on the second anniversary of the grant date and the third on the third anniversary of the grant date.